Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Prevention of Infectious Complications in Acute Pancreatitis
NCT07464392Recruiting
- Sponsor
- Changhai Hospital
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute pancreatitis (AP) comparing Fecal Microbiota Transplantation with Placebo (2 arms). Primary endpoint: Incidence of Infectious Complications at 30 days. Started Apr 2026; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT07464392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07464392.